Sinovac Biotech Ltd.  

(Public, NASDAQ:SVA)   Watch this stock  
Find more results for Sinovac
+0.04 (0.81%)
Mar 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.80 - 4.98
52 week 4.51 - 7.47
Open 4.94
Vol / Avg. 0.00/64,809.00
Mkt cap 276.74M
P/E 76.49
Div/yield     -
EPS 0.07
Shares 55.40M
Beta 0.47
Inst. own 48%
Mar 26, 2015
Q4 2014 Sinovac Biotech Ltd Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 0.62% 14.30%
Operating margin 5.21% 12.06%
EBITD margin - 21.05%
Return on average assets 0.18% 4.61%
Return on average equity 0.28% 6.04%
Employees 715 -
CDP Score - -


No.39 Shangdi Xi Road, Haidian District
+86-10-82890088 (Phone)
+86-10-62966910 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Sinovac Biotech Ltd. (Sinovac), is a holding company. The Company is an integrated China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis A and B, seasonal influenza, H5N1 and H1N1 pandemic influenza and mumps, as well as animal rabies vaccine. The Company�s product pipeline also includes human vaccines against rotavirus, and human rabies that are in pre-clinical development. The Company specializes in the sales, marketing, manufacturing, and development of vaccines for infectious disease with unmet medical need. The Company�s pipeline consists of vaccine candidates in the clinical and pre-clinical development phases in China, including the EV71 vaccine and human vaccines for pneumococcal, rotavirus, rabies, varicella and rubella.

Officers and directors

Weidong Yin Chairman of the Board, President, Chief Executive Officer, Secretary
Age: 48
Bio & Compensation  - Reuters
Nan Wang Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Ming Xia Vice President - Sales and Marketing of Sinovac Beijing
Age: 38
Bio & Compensation  - Reuters
Simon J. Anderson Independent Director
Age: 52
Bio & Compensation  - Reuters
Jue Lee Independent Director
Age: 44
Bio & Compensation  - Reuters
Yuk Lam Lo Independent Director
Age: 64
Bio & Compensation  - Reuters
Meng Mei Independent Director
Age: 58
Bio & Compensation  - Reuters